Literature DB >> 8530376

Differential glycosylation and intracellular trafficking for the long and short isoforms of the D2 dopamine receptor.

C S Fishburn1, Z Elazar, S Fuchs.   

Abstract

The D2 dopamine receptor exists in two alternatively spliced isoforms, "long" and "short" (D2L and D2S), which differ by 29 amino acids in the third cytoplasmic domain. The functional differences between these two isoforms are still obscure. We have performed pulse-chase studies on the D2L and D2S receptors expressed in CHO cells in order to follow the post-translational processing of the two isoforms. Both isoforms are present in three post-translational states: a newly synthesized protein, a partially glycosylated product, and a fully glycosylated mature 70-kDa receptor. However, the processing to the mature receptor differs between the two isoforms. First, the D2S receptor is processed to the mature 70-kDa species faster than the D2L receptor. Second, at 20 degrees C the D2S isoform is fully processed to the 70-kDa species, whereas the D2L isoform persists in its partially processed 45-kDa state. Finally, a significant portion of the D2L receptor remains in its partially processed form in an intracellular compartment and does not reach the plasma membrane. These results give rise to the suggestion that the difference observed between the two alternatively spliced isoforms of the D2 receptor may lie in their post-translational processing and intracellular trafficking.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8530376     DOI: 10.1074/jbc.270.50.29819

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

1.  Adenosine A2A receptor is involved in cell surface expression of A2B receptor.

Authors:  Kengo Moriyama; Michail V Sitkovsky
Journal:  J Biol Chem       Date:  2010-10-06       Impact factor: 5.157

2.  A functional variant of the dopamine D3 receptor is associated with risk and age-at-onset of essential tremor.

Authors:  Freddy Jeanneteau; Benoît Funalot; Joseph Jankovic; Hao Deng; Jean-Pierre Lagarde; Gérard Lucotte; Pierre Sokoloff
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-29       Impact factor: 11.205

Review 3.  Dopamine D2 autoreceptor interactome: Targeting the receptor complex as a strategy for treatment of substance use disorder.

Authors:  Rong Chen; Mark J Ferris; Shiyu Wang
Journal:  Pharmacol Ther       Date:  2020-05-27       Impact factor: 12.310

4.  Dopamine D2 receptors in addiction-like reward dysfunction and compulsive eating in obese rats.

Authors:  Paul M Johnson; Paul J Kenny
Journal:  Nat Neurosci       Date:  2010-03-28       Impact factor: 24.884

5.  The differential actions of clozapine and other antipsychotic drugs on the translocation of dopamine D2 receptors to the cell surface.

Authors:  Joseph M Schrader; Craig M Irving; J Christopher Octeau; Joseph A Christian; Timothy J Aballo; Dean J Kareemo; Joseph Conti; Jodi L Camberg; J Robert Lane; Jonathan A Javitch; Abraham Kovoor
Journal:  J Biol Chem       Date:  2019-01-22       Impact factor: 5.157

6.  Dopamine receptor expression and distribution dynamically change in the rat nucleus accumbens after withdrawal from cocaine self-administration.

Authors:  K L Conrad; K Ford; M Marinelli; M E Wolf
Journal:  Neuroscience       Date:  2010-05-07       Impact factor: 3.590

Review 7.  Chaperoning G protein-coupled receptors: from cell biology to therapeutics.

Authors:  Ya-Xiong Tao; P Michael Conn
Journal:  Endocr Rev       Date:  2014-03-24       Impact factor: 19.871

Review 8.  Pharmacoperones as Novel Therapeutics for Diverse Protein Conformational Diseases.

Authors:  Ya-Xiong Tao; P Michael Conn
Journal:  Physiol Rev       Date:  2018-04-01       Impact factor: 37.312

9.  Differential subcellular distribution of rat brain dopamine receptors and subtype-specific redistribution induced by cocaine.

Authors:  Pamela J Voulalas; John Schetz; Ashiwel S Undieh
Journal:  Mol Cell Neurosci       Date:  2011-01-12       Impact factor: 4.314

10.  Dopamine receptors in human embryonic stem cell neurodifferentiation.

Authors:  Glenn S Belinsky; Carissa L Sirois; Matthew T Rich; Shaina M Short; Anna R Moore; Sarah E Gilbert; Srdjan D Antic
Journal:  Stem Cells Dev       Date:  2013-02-19       Impact factor: 3.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.